Skip to main content

Life Sciences

Addressing Clinical Trial Challenges with Robotic Automation

The success of any given clinical trial depends heavily on the relationship between the sponsors and study sites. This is more important than ever since life sciences and healthcare companies are undergoing a digital transformation.

The evolving trend towards patient-centric trials, combined with the introduction of digital technology solutions that improve clinical trials outcomes, means there is a need for sites and investigators to be re-engaged to improve the clinical trials process. In a world where companies like Amazon, Uber, and Google are dominating and defining digital experience, life sciences companies are challenged to deliver a digital experience to their participating investigators (as well as patients) that is as equally intuitive, valuable, and beneficial as they have come to expect in other areas aspects of their lives.

A recent study found that more than 54% of investigators complete only one study with any given sponsor or CRO.

There are several contributing factors to this high turnover rate, but this fact encapsulates the urgency of the topic at hand – the relationship between the sponsor or CRO and the clinical investigators. When more than half of principal investigators (PIs) are walking away after having gone through the laborious activity of getting their site up and running, this ends up being a very expensive problem that needs to be solved quickly.

In another benchmark study, a consortium of sites and investigators used a variety of key attributes to evaluate pharmaceutical/sponsor organizations. Some of the attributes where sponsors did not score well across the board were accuracy of information, a well-informed staff, effective communication, timely resolution of issues, and overall preparedness and organization.

This guide looks at some specific clinical trial challenges concerning the pharma-investigator relationship and explores potential robotic process automation (RPA) solutions that may help address these challenges and improve sponsor reputation with investigators and sites.

To learn more about specific clinical trial challenges concerning the pharma-investigator relationship and potential solutions using robotic process automation, you can download the guide here, or fill out the form below.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Param Singh

Param Singh has been working in the life sciences industry his entire career. As the director of clinical trial management solutions at Perficient, he developed the clinical trial management team to become one of the best in the industry. Param leads a highly skilled team of implementation specialists and continues to build lasting relationships with clients. He has a knack for resource and project management, which allows clients to achieve success. Param has been with Perficient, via the acquisition of BioPharm Systems, since 2008. Prior to joining the company, he guided the clinical trial management group at Accenture.

More from this Author

Follow Us